Vipin Gopal, Eli Lilly and Company

Vipin Gopal Vipin Gopal, PhD, MBA, is the Chief Data and Analytics Officer at Eli Lilly, which he joined in early 2018. In this role, he is responsible for leading the strategy and development of advanced analytics and data science solutions across the Lilly enterprise. Vipin is a 20-year veteran in the space of advanced data and analytics, and has a significant track record of building high-performance analytics functions and creating business value with advanced analytic technologies.

His leadership experience spans four Fortune 100 companies in industries ranging from healthcare to aerospace. Before joining Eli Lilly, Vipin was the Senior Vice President of Clinical Analytics at Humana, where he was responsible for the corporate organization that developed and applied data science and analytics solutions to advance Humana’s clinical strategy, operations, quality and outcomes. Prior to Humana, he was with Cigna Healthcare, United Technologies Corporation and Honeywell.

Vipin obtained his doctorate from Carnegie Mellon University and B. Tech. from the Indian Institute of Technology (IIT), Bombay, both in engineering, and has an MBA from the New York University Stern School of Business. In recognition of his leadership contributions in the space of data and analytics, he was listed as a ‘2018 Top 100 Innovator in Data and Analytics’ and was awarded the 2015 Analytics Leadership Award by Indiana University Kelly School of Business. Dr. Gopal has served on the organizing/advisory committees of many national and international analytic conferences, and is a frequent speaker on the transformational power of advanced analytics for a broad range of strategic topics in healthcare.

Vipin is a passionate advocate of educational initiatives and developing an empowered and diverse workforce. Most recently, he served as Chair of the Advisory Board of Greater Louisville International Professionals (GLIP), and as a member of the Board of Directors of Jefferson Community and Technical College (JCTC) Foundation.

Session

9:00 AM - 9:40 AM

Executive Viewpoints: Will AI Be Innovation or Renovation for Biopharma?

Moderator

Speakers

  • Birgit Schoeberl, Ph.D

    Birgit Schoeberl, Ph.D Global Head of Modeling and Simulation, PK Sciences Novartis Institutes for BioMedical Research (NIBR)

  • Vipin Gopal

    Vipin Gopal Chief Data and Analytics Officer Eli Lilly and Company


Download Latest Agenda